Vitamins While on Ozempic: Safety, Absorption & Timing

Last reviewed: May 28, 2026

Last updated: May 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, you can generally take vitamins while on Ozempic or other GLP-1 medications, but timing, formulation, and individual absorption capacity matter significantly. GLP-1 receptor agonists slow gastric emptying—the rate at which food and supplements move through your stomach—which may alter how certain nutrients are absorbed.

This distinction is crucial for patients pursuing long-term GLP-1 therapy. Understanding how your body processes micronutrients, combined with genetic or biomarker data about your metabolism, supports a more tailored nutritional strategy that complements your medication protocol.

How GLP-1 Medications Affect Nutrient Absorption

GLP-1 receptor agonists, including semaglutide and tirzepatide, work partly by delaying gastric emptying. This slower transit time through the digestive tract can reduce the absorption window for fat-soluble vitamins, B vitamins, and minerals that depend on specific pH environments or intestinal transit speed.

Studies show vitamin B12 absorption may decrease by 10–15% in some patients on GLP-1 therapy, particularly with prolonged use. Iron, calcium, and fat-soluble vitamins (A, D, E, K) may also be affected, especially if nausea or reduced food intake accompanies early treatment phases.

Timing, Formulation, and Nutrient Bioavailability Framework

Strategic timing and form selection optimize vitamin absorption during GLP-1 therapy. Below is a framework comparing common nutrient types and evidence-based recommendations for patients on these medications.

Nutrient Type	Absorption Challenge	Recommended Strategy	Monitoring Consideration
Vitamin B12	Reduced intrinsic factor activity; slower GI transit	Sublingual or intramuscular form; separate from meals by 2+ hours	Annual B12 levels; consider supplementation at 500–1000 mcg weekly
Fat-soluble vitamins (A, D, E, K)	Require bile and slower transit for optimal absorption	Take with smallest amount of fat present; consider liquid or emulsified forms	Baseline and annual 25-OH vitamin D; fat-soluble vitamin panel every 6–12 months
Iron	Gastric pH changes; competition with GLP-1 side effects	Ferrous forms on empty stomach 2+ hours before/after medication; avoid with calcium	Ferritin and iron saturation annually; watch for fatigue or pallor
Calcium & Magnesium	Slower GI transit reduces window for active absorption	Divide doses to 500 mg or less per dose; space 4+ hours from other supplements	Serum and ionized calcium, magnesium levels; assess for muscle weakness or cramping

Early-Phase GLP-1 Therapy and Micronutrient Risk

The first 4–8 weeks of GLP-1 treatment often involve nausea, reduced appetite, and food aversion. These factors compound the medication's effect on absorption, creating a window where micronutrient intake and bioavailability are both compromised.

Patients may unconsciously reduce intake of nutrient-dense foods, leading to cumulative deficiencies in iron, B vitamins, and protein. Baseline micronutrient screening before starting therapy—including serum B12, folate, iron panel, and vitamin D—helps providers identify vulnerabilities and set appropriate monitoring schedules.

Safety Considerations, Drug-Nutrient Interactions, and Provider Guidance

Most over-the-counter vitamins are safe to take with GLP-1 medications, but certain supplements may interact or be less effective. Calcium and iron should be spaced several hours from your GLP-1 injection or oral dose. Medications that reduce stomach acid (such as proton pump inhibitors) compound vitamin B12 and mineral absorption challenges.

Work with your healthcare provider to establish a baseline micronutrient profile before initiating GLP-1 therapy. This approach allows your provider to detect deficiencies early, adjust supplementation timing, and monitor for symptoms of inadequate nutrient status—fatigue, muscle weakness, hair loss, or bone density changes—throughout your treatment.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals genetic variants that influence nutrient metabolism pathways relevant to GLP-1 therapy. For instance, variants in genes affecting B12 metabolism, iron transport, and vitamin D synthesis may help identify patients at higher risk for deficiency during medication use. This genetic context may help provide a more complete picture before starting therapy.

The test does not predict your exact nutrient needs or supplement response—that requires clinical evaluation and biomarker follow-up. However, understanding your genetic predispositions in metabolic pathways can support a more informed conversation with your provider about baseline screening priorities and monitoring frequency.

Patients considering compounded GLP-1 medications like our semaglutide or tirzepatide options should discuss their micronutrient status with their provider. Combining genetic insights with clinical biomarkers creates a stronger foundation for safe, personalized nutrient management during treatment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.